In the realm of gene therapy and genetic engineering, viral vectors have emerged as indispensable tools for delivering genetic material to cells. These modified viruses possess the ability to ...

Todd Przybycien, Ph.D., professor of chemical and biological engineering at RPI, has been named head of RPI’s Howard P.

A cellular engineering breakthrough: High-yield CRISPR without viral vectors (Nanowerk News) A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of ...

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against the variola virus, the causative agent of smallpox, and has therefore ...

“Using viral vectors is expensive and resource intensive,” says Shy. “A major benefit of a non-viral approach to gene engineering is that we’re not as limited by cost, manufacturing ...

Vectors, both viral and non-viral, continue to further progress gene therapy for a variety of disease states. With further innovation, the approaches can expand their reach even further.

Now is the time to make sure that your data infrastructure can handle the speed, scale and performance necessary to succeed in this new world.